vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Porch Group, Inc. (PRCH). Click either name above to swap in a different company.
Porch Group, Inc. is the larger business by last-quarter revenue ($121.1M vs $83.5M, roughly 1.5× BillionToOne, Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs -3.9%, a 10.7% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 100.0%).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Porch is a website that tries to connect homeowners with local home improvement contractors. The site features advice articles, cost guide, and online booking for over 160 home projects.
BLLN vs PRCH — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $121.1M |
| Net Profit | $5.7M | $-4.7M |
| Gross Margin | 69.9% | 52.7% |
| Operating Margin | 11.5% | 34.7% |
| Net Margin | 6.8% | -3.9% |
| Revenue YoY | 117.4% | 100.0% |
| Net Profit YoY | 138.3% | 2.0% |
| EPS (diluted) | $0.10 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $121.1M | ||
| Q4 25 | — | $112.3M | ||
| Q3 25 | $83.5M | $115.1M | ||
| Q2 25 | — | $107.0M | ||
| Q1 25 | — | $84.5M | ||
| Q4 24 | — | $75.3M | ||
| Q3 24 | $38.4M | $77.7M | ||
| Q2 24 | — | $75.9M |
| Q1 26 | — | $-4.7M | ||
| Q4 25 | — | $-3.5M | ||
| Q3 25 | $5.7M | $-10.9M | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | $8.4M | ||
| Q4 24 | — | $30.5M | ||
| Q3 24 | $-14.9M | $14.4M | ||
| Q2 24 | — | $-64.3M |
| Q1 26 | — | 52.7% | ||
| Q4 25 | — | 99.5% | ||
| Q3 25 | 69.9% | 75.6% | ||
| Q2 25 | — | 70.9% | ||
| Q1 25 | — | 77.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | 52.6% | 79.4% | ||
| Q2 24 | — | 22.1% |
| Q1 26 | — | 34.7% | ||
| Q4 25 | — | 14.7% | ||
| Q3 25 | 11.5% | 14.2% | ||
| Q2 25 | — | 4.7% | ||
| Q1 25 | — | -1.5% | ||
| Q4 24 | — | 33.3% | ||
| Q3 24 | -32.9% | -3.2% | ||
| Q2 24 | — | -69.2% |
| Q1 26 | — | -3.9% | ||
| Q4 25 | — | -3.1% | ||
| Q3 25 | 6.8% | -9.4% | ||
| Q2 25 | — | 2.4% | ||
| Q1 25 | — | 9.9% | ||
| Q4 24 | — | 40.5% | ||
| Q3 24 | -38.8% | 18.5% | ||
| Q2 24 | — | -84.8% |
| Q1 26 | — | $-0.04 | ||
| Q4 25 | — | $0.00 | ||
| Q3 25 | $0.10 | $-0.10 | ||
| Q2 25 | — | $0.00 | ||
| Q1 25 | — | $0.07 | ||
| Q4 24 | — | $0.34 | ||
| Q3 24 | $-1.47 | $0.12 | ||
| Q2 24 | — | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $68.4M |
| Total DebtLower is stronger | $55.0M | $391.3M |
| Stockholders' EquityBook value | $-239.5M | $26.3M |
| Total Assets | $327.5M | $806.6M |
| Debt / EquityLower = less leverage | — | 14.87× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $68.4M | ||
| Q4 25 | — | $57.3M | ||
| Q3 25 | $195.2M | $85.0M | ||
| Q2 25 | — | $79.8M | ||
| Q1 25 | — | $70.4M | ||
| Q4 24 | — | $191.7M | ||
| Q3 24 | — | $238.6M | ||
| Q2 24 | — | $308.4M |
| Q1 26 | — | $391.3M | ||
| Q4 25 | — | $392.8M | ||
| Q3 25 | $55.0M | $387.1M | ||
| Q2 25 | — | $394.1M | ||
| Q1 25 | — | $409.2M | ||
| Q4 24 | — | $403.9M | ||
| Q3 24 | — | $399.0M | ||
| Q2 24 | — | $436.8M |
| Q1 26 | — | $26.3M | ||
| Q4 25 | — | $-24.6M | ||
| Q3 25 | $-239.5M | $-27.9M | ||
| Q2 25 | — | $-29.3M | ||
| Q1 25 | — | $-52.4M | ||
| Q4 24 | — | $-43.2M | ||
| Q3 24 | $-242.9M | $-77.0M | ||
| Q2 24 | — | $-101.9M |
| Q1 26 | — | $806.6M | ||
| Q4 25 | — | $797.4M | ||
| Q3 25 | $327.5M | $787.7M | ||
| Q2 25 | — | $770.7M | ||
| Q1 25 | — | $802.3M | ||
| Q4 24 | — | $814.0M | ||
| Q3 24 | — | $867.3M | ||
| Q2 24 | — | $876.1M |
| Q1 26 | — | 14.87× | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | — |
| Free Cash FlowOCF − Capex | $6.5M | — |
| FCF MarginFCF / Revenue | 7.7% | — |
| Capex IntensityCapex / Revenue | 8.8% | — |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $1.2M | ||
| Q3 25 | $13.8M | $40.8M | ||
| Q2 25 | — | $35.6M | ||
| Q1 25 | — | $-11.2M | ||
| Q4 24 | — | $-26.6M | ||
| Q3 24 | — | $12.4M | ||
| Q2 24 | — | $-26.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $1.1M | ||
| Q3 25 | $6.5M | $40.7M | ||
| Q2 25 | — | $35.4M | ||
| Q1 25 | — | $-11.2M | ||
| Q4 24 | — | $-26.8M | ||
| Q3 24 | — | $12.2M | ||
| Q2 24 | — | $-26.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.0% | ||
| Q3 25 | 7.7% | 35.4% | ||
| Q2 25 | — | 33.0% | ||
| Q1 25 | — | -13.3% | ||
| Q4 24 | — | -35.6% | ||
| Q3 24 | — | 15.7% | ||
| Q2 24 | — | -34.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | 8.8% | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | 13.79× | ||
| Q1 25 | — | -1.33× | ||
| Q4 24 | — | -0.87× | ||
| Q3 24 | — | 0.86× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
PRCH
Segment breakdown not available.
